A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

10K views

⸱

DOI:

10.3791/57685

⸱

June 7th, 2018

 ,  , 

* These authors contributed equally

In This Article

Summary

Here we describe a method to separate and enrich components of the tumor immune and non-immune microenvironment in established subcutaneous tumors. This technique allows for the separate analysis of tumor immune infiltrate and non-immune tumor fractions which can permit comprehensive characterization of the tumor immune microenvironment.

Abstract

The tumor immune microenvironment (TIME) has recently been recognized as a critical mediator of treatment response in solid tumors, especially for immunotherapies. Recent clinical advances in immunotherapy highlight the need for reproducible methods to accurately and thoroughly characterize the tumor and its associated immune infiltrate. Tumor enzymatic digestion and flow cytometric analysis allow broad characterization of numerous immune cell subsets and phenotypes; however, depth of analysis is often limited by fluorophore restrictions on panel design and the need to acquire large tumor samples to observe rare immune populations of interest. Thus, we have developed an effective and high throughput method for separating and enriching the tumor immune infiltrate from the non-immune tumor components. The described tumor digestion and centrifugal density-based separation technique allows separate characterization of tumor and tumor immune infiltrate fractions and preserves cellular viability, and thus, provides a broad characterization of the tumor immunologic state. This method was used to characterize the extensive spatial immune heterogeneity in solid tumors, which further demonstrates the need for consistent whole tumor immunologic profiling techniques. Overall, this method provides an effective and adaptable technique for the immunologic characterization of subcutaneous solid murine tumors; as such, this tool can be used to better characterize the tumoral immunologic features and in the preclinical evaluation of novel immunotherapeutic strategies.

Introduction

The suppressive TIME has recently been recognized as a hallmark of cancer, and is known to play a significant role in the development, progression, and protection of solid tumor cancers as well as mitigate their susceptibility to immunotherapy1. The TIME is composed of numerous cellular subsets and phenotypes, all of which provide critical insight into the immunologic state of the tumor. These immunologic subsets can be further stratified into cells of lymphocyte or myeloid origin, which together constitute the majority of the innate and adaptive immune responses2,3. Recent advances in ....

Access restricted. Please log in or start a trial to view this content.

Protocol

All methods described here have been approved by the Institutional Animal Care and Use Committee (IACUC) of Baylor College of Medicine.

1. Tumor Harvest and Digestion

NOTE: The time required for harvest is ~3 - 5 min/tumor, and the time required for processing is ~1 h + 2 - 3 min/tumor.

  1. Euthanize mice by carbon dioxide inhalation and spray each mouse down with 70% ethanol before harvesting to prevent hair contamination. Surgically remove subcutaneous tumors from the mice and ensure that the tumors are free of any contaminating tissue (i.e., hair, skin, peritoneum, etc.). Place each t....

Access restricted. Please log in or start a trial to view this content.

Results

Our results demonstrate the significant benefit of TIL separation from non-immune tumor components, as explained in the protocol. Additionally, using the described method we demonstrate the significant immunologic heterogeneity of established solid tumors.

A significant problem with many tumor dissociation techniques is the loss of sample viability, most often as a result of harsh digestion conditions (i.e., elevated te.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The TIME is composed of diverse and complex cellular components and molecules. Recent evidence suggests that accurate characterization of this environment can provide a better understanding of treatment success or failure, and can even help identify mechanisms of therapeutic resistance. For example, increasing intratumoral levels of various immunosuppressive cells (i.e., MDSCs, T regulatory cells, etc.) can mitigate effector immune responses and abrogate immunotherapeutic effects. On the other hand, the.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

JMN acknowledges financial support from National Institute of General Medical Sciences (T32GM088129) and the National Institute of Dental & Craniofacial Research (F31DE026682) both of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This project was also supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the NIH (P30 AI036211, P30 CA125123, and S10 RR024574) and the expert assistance of Joel M. Sederstrom.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
6 to 12 week old male C57BL/6 miceJackson Laboratory N/AMice used in our tumor studies
MEER Murine Syngeneic Cancer Cell lineAcquired from collaborator N/AE6/E7 HPV antigen expressing murine tonsillar epithelial cancer cell line 
70% isopropyl alcohol EMD Milipore PX1840
Murine surgical tool kitWorld Precision InstrumentsMOUSEKITPrimarily only need scissors, tweezers, and a scalpel. 
24-well plate Denville Scientific Inc.T1024Or any 24-well flat bottom plate. 
RPMI-1640 mediaSigma-AldrichR0883
Collagenase I EMD Milipore234153
Collagenase IVWorthington Biochemical CorporationLS004189
DNase I Sigma-Aldrich11284932001
Low Speed Orbital ShakerBioExpress (supplier: Genemate) S-3200-LSOr any orbital shaker. 
Thermoregulating incubatorFisher Scientific13-255-27Or any other thermo-regulated incubator
FBSSigma-AldrichF8192
EDTAAMRESCOE177
1 mL Pipette and tipsEppendorf13-690-032Or any other pipette and tips
40 um Cell StrainersFisher Scientific22363547
50 mL Centrifuge TubesDenville Scientific Inc.C1062-P
15 mL Conical TubesDenville Scientific Inc.C1012
10 mL Luer-Lok Syringe without needlesBD309604
Lymphoprep Density Gradient MediumSTEMCELL Technologies7811
Transfer PipettesDenville Scientific Inc.P7212
96-well U-bottom platesDenville Scientific Inc.
DPBSSigma Aldrich D8573
FoxP3 Transcription Factor Staining Buffer Set ThermoFisher Scientific00-5523-00Fix/Permeabilization Buffer and Permeabilization Buffer
Thermoregulated CentrifugeEppendorf 5810 R
Attune NxT Flow CytometerThermoFisher ScientificN/AFor 96-well cell volumetric counting 
Purified Rat Anti-Mouse CD16/CD32 (Mouse BD Fc Block) Clone 2.4G2 ThermoFisher Scientific553141Fc Block
LIVE/DEAD Fixable Blue Dead Cell Stain Kit, for UV excitationThermoFisher ScientificL34962Fixable viability stain
CD45 Monoclonal Antibody (30-F11), APC-eFluor 780ThermoFisher Scientific47-0451-80
TCR beta Monoclonal Antibody (H57-597), APCThermoFisher Scientific17-5961-82
CD8-α Antibody (KT15), PESanta Cruz Biotechnologysc-53473 
CD4 Monoclonal Antibody (GK1.5), PE-Cyanine5ThermoFisher Scientific15-0041-81
MHC Class II (I-A/I-E) Monoclonal Antibody (M5/114.15.2), Alexa Fluor 700ThermoFisher Scientific56-5321-82
CD11c Monoclonal Antibody (N418), PE-Cyanine5ThermoFisher Scientific15-0114-82
F4/80 Monoclonal Antibody (BM8), eFluor 450ThermoFisher Scientific48-4801-80
CD11b Monoclonal Antibody (M1/70), APCThermoFisher Scientific17-0112-81
Ly-6G (Gr-1) Monoclonal Antibody (RB6-8C5), PEThermoFisher Scientific12-5931-82
CD274 (PD-L1, B7-H1) Monoclonal Antibody (MIH5), PE-Cyanine7ThermoFisher Scientific25-5982-80
CD273 (B7-DC) Monoclonal Antibody (122), PerCP-eFluor 710ThermoFisher Scientific46-9972-82
Ki-67 Monoclonal Antibody (B56), BV711BD Biosciences563755

References

  1. Fouad, Y. A., Aanei, C. Revisiting the hallmarks of cancer. American Journal of Cancer Research. 7 (5), 1016-1036 (2017).
  2. Gajewski, T. F., Schreiber, H., Fu, Y. -X. Innate and adaptive immune cells in the tumor microenvironment. Nature Immunology. 14 (10), 1014-1022 (2013).
  3. Whiteside, T. L.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Tumor Immune MicroenvironmentFlow Cytometry AnalysisTumor Enzymatic DigestionDensity Gradient SeparationImmune Cell EnrichmentTumor Infiltrating LeukocytesCD45 Positive CellsCell Viability AssessmentImmunophenotyping Panel